NYSE:NUE
NYSE:NUEMetals and Mining

Nucor (NYSE:NUE) Projects Q2 Earnings of US$3 Per Share Adjusting from Q1

Nucor (NYSE:NUE) recently provided new earnings guidance for the second quarter ending July 5, 2025, expecting earnings between $2.55 and $2.65 per diluted share. Although this projection is a decline from the $2.68 per diluted share reported in the same quarter the previous year, it is significantly higher than the $0.67 reported in Q1 2025. This guidance, along with the announcement of its regular quarterly cash dividend, might have supported a 5% price movement over the last month. While...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments (NasdaqGS:TXN) Announces US$60 Billion Investment in American Semiconductor Manufacturing

Texas Instruments (NasdaqGS:TXN) recently announced a substantial $60 billion investment to build seven semiconductor fabs in the U.S., aiming to strengthen domestic manufacturing and collaborate with companies like Ford, Medtronic, and NVIDIA. Over the last quarter, the company's stock price increased by 9%. This aligns closely with broader market trends, as both Texas Instruments and market indices have posted similar gains. This expansion and strategic collaborations could have added...
TSX:CLS
TSX:CLSElectronic

Celestica (TSX:CLS) Shareholders Approve Advance Notice By-Law at Annual Meeting

Celestica (TSX:CLS), following its shareholders' approval of the new By-Law 2 (Advance Notice), experienced a 37% increase over the last quarter. This rise could be supported by strong market conditions characterized by the Dow Jones and S&P 500 maintaining a positive stance amidst interest rate decisions and Middle East tensions. Additionally, Celestica's Q1 earnings report showed increased sales and an upward revision in revenue guidance, which may have contributed positively to the stock's...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol-Myers Squibb (NYSE:BMY) Declares US$0.62 Common and US$0.50 Preferred Dividends

Bristol-Myers Squibb (NYSE:BMY) recently announced dividend declarations for common and preferred stock, potentially adding some weight to the company's stock performance over the past month. The stock saw a modest gain of 1%, which aligns closely with broader market movements amid geopolitical and economic factors such as the Middle Eastern conflict and anticipation around the Federal Reserve's decision on interest rates. Additionally, updates regarding clinical trial results for product...
NasdaqCM:DCGO
NasdaqCM:DCGOHealthcare

DocGo Leads The Pack Of 3 Promising Penny Stocks

As global markets remain on edge due to geopolitical tensions and the impending Federal Reserve rate decision, investors are cautiously optimistic with major indices showing modest gains. For those willing to explore beyond established market giants, penny stocks—often representing smaller or newer companies—offer intriguing possibilities. While the term may seem outdated, these stocks continue to present unique growth opportunities at lower price points, especially when supported by strong...
NasdaqCM:NXTT
NasdaqCM:NXTTSoftware

Three Undiscovered Gems in the US Market

As global markets navigate the uncertainties stemming from geopolitical tensions and anticipate the Federal Reserve's upcoming interest rate decision, investors are closely monitoring the impact on small-cap stocks within indices like the S&P 600. Amid this backdrop of volatility and fluctuating oil prices, identifying promising investment opportunities in less-explored areas of the U.S. market can be a strategic move for those looking to diversify their portfolios.